ARG1 and neoplasm: Notably, the expression of Arg-1—a hallmark of M2-TAMs linked to immunosuppression and tumor progression [31]—showed a downward trend in Arg-1+TAMs post-treatment, although statistical significance was not reached (p > 0.05; Fig. 4E).